Tianjin Chase Sun Pharmaceutical

Tianjin Chase Sun Pharmaceutical is one of the...

• CSI 500.

Tianjin Chase Sun Pharmaceutical is a company listed under the stock ticker 300026 (CN).

View the org chart displaying its 16 main executives

Most searched biographies at Tianjin Chase Sun Pharmaceutical

• Dan Zheng, General Manager and Vice Chairman of the Board
• Wu Sun, Director
• Dawei Miao, Director

Create your alert
to follow the executive moves at Tianjin Chase Sun Pharmaceutical.

Tianjin Chase Sun Pharmaceutical has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Tianjin Chase Sun Pharmaceutical

Social media about Tianjin Chase Sun Pharmaceutical

• Tianjin Chase Sun Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Chase Sun Pharmaceutical on LinkedIn, Twitter & YouTube

Call Tianjin Chase Sun Pharmaceutical at +86 225...

View the org chart

Register to receive your alert

Report an error